Serica Technologies
Serica Technologies, Inc., a medical device company, develops silk-based biomaterial platforms that are used in tissue repair caused by disease, trauma, or aging. The company offers SeriGel, a long-term bioresorbable silk hydrogel that is used in plastic and reconstructive surgery, and drug delivery; and SeriFascia surgical scaffold implant, which enables the reestablishment of functional collagen sheet-like tissue that has diminished as a result of either surgery or aging. It also provides SeriACL graft, a biocompatible and biodegradable ligament graft that is used for anterior cruciate ligament (ACL) repair; SeriCuff scaffold, which is used in rotator cuff tendon repair; and SeriScaffold surgical mesh that is used to repair and remodel damaged connective tissues. The company’s products are used in orthopedics and sports medicine, aesthetic and reconstructive plastic surgery, and multiple additional structural tissue repair applications. Serica Technologies was formerly known as Tissue Regeneration, Inc. and changed its name to Serica Technologies, Inc. in 2006. The company was founded in 1998 and is based in Medford, Massachusetts. As of February 4, 2010, Serica Technologies, Inc. operates as a subsidiary of Allergan Inc.
Milestones
Videos
Screenshots
Sources
-
Allergan buys Serica Tech (fiercebiotech.com) [edit]
